Simponi under the microscope: new registry tracks Long-Term risks in ulcerative colitis patients
NCT ID NCT02808780
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry follows 535 adults with moderate-to-severe ulcerative colitis who are taking or starting Simponi. Researchers will track serious side effects like infections, cancers, and pregnancy outcomes over time. The goal is to better understand the long-term safety of this medication in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Simponi (golimumab)
What this could lead to
If successful, this registry will provide a clearer picture of Simponi's long-term safety, helping doctors and patients make more informed treatment decisions.
What could go wrong
This is an observational registry, not a treatment trial, so it won't test new therapies. Results may not apply to all patients, and rare side effects might still be missed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Murrieta, California, United States
-
Study site
Rialto, California, United States
-
Study site
Ventura, California, United States
-
Study site
Coral Gables, Florida, United States
-
Study site
Fort Myers, Florida, United States
-
Study site
Lake Worth, Florida, United States
-
Study site
Lauderdale Lakes, Florida, United States
-
Study site
Miami, Florida, United States
-
Study site
Tampa, Florida, United States
-
Study site
Suwanee, Georgia, United States
-
Study site
Chicago, Illinois, United States
-
Study site
Sylvania, Ohio, United States
-
Study site
Pittsburgh, Pennsylvania, United States
-
Study site
Houston, Texas, United States
-
Study site
San Antonio, Texas, United States
-
Study site
Lansdowne Town Center, Virginia, United States
-
Study site
Salzburg, Austria
-
Study site
Sankt Poelten Noe, Austria
-
Study site
Vienna, Austria
-
Study site
New Westminster, British Columbia, Canada
-
Study site
Vancouver, British Columbia, Canada
-
Study site
Oshawa, Ontario, Canada
-
Study site
Ottawa, Ontario, Canada
-
Study site
Pilsen, Czechia
-
Study site
Clermont-Ferrand, France
-
Study site
Clichy, France
-
Study site
Créteil, France
-
Study site
Grenoble, France
-
Study site
Montpellier, France
-
Study site
Nice, France
-
Study site
Pierre-Bénite, France
-
Study site
Saint-Priest-en-Jarez, France
-
Study site
Strasbourg, France
-
Study site
Berlin, Germany
-
Study site
Dessau Roblau, Germany
-
Study site
Halle, Germany
-
Study site
Hamburg, Germany
-
Study site
Heidelberg, Germany
-
Study site
Kiel, Germany
-
Study site
Leipzig, Germany
-
Study site
Ludwigshafen, Germany
-
Study site
Lyneburg, Germany
-
Study site
München, Germany
-
Study site
Saarbrücken, Germany
-
Study site
Athens, Greece
-
Study site
Heraklion, Greece
-
Study site
Ioannina, Greece
-
Study site
Thessaloniki, Greece
-
Study site
Busan, South Korea
-
Study site
Gyeonggi-do, South Korea
-
Study site
Seongnam-si, South Korea
-
Study site
Seoul, South Korea
-
Study site
A Coruña, Spain
-
Study site
Barcelona, Spain
-
Study site
Córdoba, Spain
-
Study site
Fuenlabrada, Spain
-
Study site
Huelva, Spain
-
Study site
Madrid, Spain
-
Study site
Majadahonda, Spain
-
Study site
San Sebastián de los Reyes, Spain
-
Study site
Valencia, Spain
-
Study site
Vigo, Spain
-
Study site
Zaragoza, Spain